Extrahepatic Manifestations of Chronic Hepatitis C Virus (HCV) Infection

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Apr 2

PMID 38562366

Authors

Bella Garg

Amirmohsen Arbabi

Purnell A Kirkland

Affiliations

Soon will be listed here.

Abstract

Hepatitis C virus (HCV) is a well-recognized, major cause of various liver-related conditions such as chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Apart from liver disease, chronic HCV infection is also associated with several extrahepatic manifestations that can lead to significant morbidity and mortality. These extrahepatic manifestations include essential mixed cryoglobulinemia (EMC), lymphomas, porphyria cutanea tarda, lichen planus, necrolytic acral erythema, glomerulonephritis, subclinical autoantibody formation, immune thrombocytopenia, thyroid disease, Sjögren's disease/sicca symptoms, diabetes mellitus, ocular diseases, musculoskeletal disorders, cardiovascular diseases, neurocognitive dysfunction, and leukocytoclastic vasculitis. We are presenting a case of chronic HCV infection linked to the extrahepatic manifestations of the disease which can be directly related to HCV or indirectly related to EMC from HCV. An awareness and knowledge of these extrahepatic manifestations will highlight the importance of recognizing the symptoms for an early diagnosis and effective anti-viral treatment in order to improve or resolve the long-term complications of chronic HCV infection.

References

Di Muzio A, Bonetti B, Capasso M, Panzeri L, Pizzigallo E, Rizzuto N . Hepatitis C virus infection and myositis: a virus localization study. Neuromuscul Disord. 2002; 13(1):68-71. DOI: 10.1016/s0960-8966(02)00184-0. View

Mazzaro C, Quartuccio L, Adinolfi L, Roccatello D, Pozzato G, Nevola R . A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy. Viruses. 2021; 13(11). PMC: 8619859. DOI: 10.3390/v13112249. View

Viegi G, Fornai E, Ferri C, Di Munno O, Begliomini E, Vitali C . Lung function in essential mixed cryoglobulinemia: a short-term follow-up. Clin Rheumatol. 1989; 8(3):331-8. DOI: 10.1007/BF02030345. View

Cacoub P, Comarmond C, Domont F, Savey L, Desbois A, Saadoun D . Extrahepatic manifestations of chronic hepatitis C virus infection. Ther Adv Infect Dis. 2016; 3(1):3-14. PMC: 4735500. DOI: 10.1177/2049936115585942. View

David W, Peine C, Schlesinger P, Smith S . Nonsystemic vasculitic mononeuropathy multiplex, cryoglobulinemia, and hepatitis C. Muscle Nerve. 1996; 19(12):1596-602. DOI: 10.1002/(SICI)1097-4598(199612)19:12<1596::AID-MUS9>3.0.CO;2-5. View

Moorman J, Saad M, Kosseifi S, Krishnaswamy G . Hepatitis C virus and the lung: implications for therapy. Chest. 2005; 128(4):2882-92. DOI: 10.1378/chest.128.4.2882. View

Younossi Z, Park H, Henry L, Adeyemi A, Stepanova M . Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden. Gastroenterology. 2016; 150(7):1599-1608. DOI: 10.1053/j.gastro.2016.02.039. View

Daoud M, Gibson L, Daoud S, El-Azhary R . Chronic hepatitis C and skin diseases: a review. Mayo Clin Proc. 1995; 70(6):559-64. DOI: 10.4065/70.6.559. View

Levey A, Atkins R, Coresh J, Cohen E, Collins A, Eckardt K . Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007; 72(3):247-59. DOI: 10.1038/sj.ki.5002343. View

10.

Buezo G, Rios-Buceta L, Borque M, Aragues M, Dauden E . Cryoglobulinemia and cutaneous leukocytoclastic vasculitis with hepatitis C virus infection. Int J Dermatol. 1996; 35(2):112-5. DOI: 10.1111/j.1365-4362.1996.tb03273.x. View

11.

Villanova M, Caudai C, Sabatelli P, Toti P, Malandrini A, Luzi P . Hepatitis C virus infection and myositis: a polymerase chain reaction study. Acta Neuropathol. 2000; 99(3):271-6. DOI: 10.1007/pl00007437. View

12.

Gonzalez-Calvin J, Munoz-Torres M, Mundi J . Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology. 1998; 28(3):695-9. DOI: 10.1002/hep.510280315. View

13.

Sherman A, Sherman K . Extrahepatic manifestations of hepatitis C infection: navigating CHASM. Curr HIV/AIDS Rep. 2015; 12(3):353-61. PMC: 4554601. DOI: 10.1007/s11904-015-0274-8. View

14.

Ramos-Casals M, Trejo O, Garcia-Carrasco M, Cervera R, Font J . Mixed cryoglobulinemia: new concepts. Lupus. 2000; 9(2):83-91. DOI: 10.1191/096120300678828127. View

15.

Johnson R, Gretch D, Couser W, Alpers C, Wilson J, Chung M . Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int. 1994; 46(6):1700-4. DOI: 10.1038/ki.1994.471. View

16.

Bertorelli G, Pesci A, Manganelli P, Schettino G, Olivieri D . Subclinical pulmonary involvement in essential mixed cryoglobulinemia assessed by bronchoalveolar lavage. Chest. 1991; 100(5):1478-9. DOI: 10.1378/chest.100.5.1478b. View

17.

Khosla S, Hassoun A, Baker B, Liu F, Zein N, Whyte M . Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults. J Clin Invest. 1998; 101(10):2165-73. PMC: 508804. DOI: 10.1172/JCI1111. View

18.

Lo Re 3rd V, Volk J, Newcomb C, Yang Y, Freeman C, Hennessy S . Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection. Hepatology. 2012; 56(5):1688-98. PMC: 3433632. DOI: 10.1002/hep.25866. View

19.

McGuire B, Julian B, Bynon Jr J, Cook W, King S, Curtis J . Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med. 2006; 144(10):735-41. DOI: 10.7326/0003-4819-144-10-200605160-00007. View

20.

Weinberger A, Berliner S, Pinkhas J . Articular manifestations of essential cryoglobulinemia. Semin Arthritis Rheum. 1981; 10(3):224-9. DOI: 10.1016/s0049-0172(81)80004-2. View